DekaBank Deutsche Girozentrale’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$140K	–	1118
2020 Q1	$140K	Buy	+3,000	New	+$140K	﹤0.01%	919

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RARX Position: Q2 2020 in Review

DekaBank Deutsche Girozentrale sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 3,000 shares — an estimated $140K sold.

DekaBank Deutsche Girozentrale first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $140K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

DekaBank Deutsche Girozentrale reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 3,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $140K.
DekaBank Deutsche Girozentrale first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
DekaBank Deutsche Girozentrale's Ra Pharmaceuticals, Inc. Common Stock position peaked at $140K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2020, filed 4 Aug 2020.